SCHEMBL21974072

SCHEMBL21974072

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccc(-c6ccc7ccccc7c6)cc5)cc4)c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HDAC4 P56524 1/20 0.36
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35
TUBB2A Q13885 1/20 0.35
TUBB8 Q3ZCM7 1/20 0.35
TUBA3E Q6PEY2 1/20 0.35
TUBA1A Q71U36 1/20 0.35
TUBA1C Q9BQE3 1/20 0.35
TUBB6 Q9BUF5 1/20 0.35
TUBB2B Q9BVA1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24827691 1.00 KDM4E (0.41) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21973962 0.95 L3MBTL1 (0.41) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21973869 0.95 L3MBTL1 (0.41) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21970837 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21971302 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21973723 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL24827699 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21971465 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21971291 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4ESR1
SCHEMBL21972495 0.95 KDM4E (0.46) KDM4EATML3MBTL1HDAC4ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11545630-B2 Compound and organic electroluminescent device comprising the same LG DISPLAY CO., LTD. (KR) 2023-01-03 US disclosed
US-20200144509-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME MATERIAL SCIENCE CO., LTD. (KR) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11545630-B2 Compound and organic electroluminescent device comprising the same PIEZO1, KCNN2, ORAI2 KDM4E 1244/4885ATM 3340/4885L3MBTL1 467/4885
US-20200144509-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME PIEZO1, KCNN2, HCN2 KDM4E 1210/4885ATM 3220/4885L3MBTL1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.